- $165.86bn
- $228.49bn
- $58.50bn
- 58
- 59
- 87
- 75
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 41,172 | 41,651 | 81,288 | 100,330 | 58,496 |
Cost of Revenue | |||||
Gross Profit | 33,129 | 33,246 | 50,602 | 66,233 | 40,707 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 29,061 | 34,117 | 57,802 | 64,093 | 59,425 |
Operating Profit | 12,111 | 7,534 | 23,486 | 36,237 | -929 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11,485 | 7,036 | 24,311 | 34,729 | 1,058 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10,545 | 6,666 | 22,459 | 31,401 | 2,173 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 16,273 | 9,159 | 21,980 | 31,372 | 2,119 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 16,272 | 9,159 | 21,979 | 31,372 | 2,119 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.23 | 1.45 | 5.12 | 6.28 | 3.2 |
Dividends per Share |